Biocair Develops Dedicated Team for Cell and Gene Therapy Logistics
Biocair (Cambridge, UK) has created a specialist logistics team to meet the complex needs of the rapidly expanding cell and gene therapy (CGT) sector.
The company is continuing to develop a team of over 30 dedicated specialists to deliver 24-hour global support for cell and gene therapy service users, it is reported.
The investment, says Biocair, will position the company “at the forefront of personalized logistics, connecting innovative drug developers with patients.”
Biocair plans to double the size of the team over the next 12 months. The company plans to recruit personnel in key regions, including Europe, the Middle East and Africa (EMEA), Asia-Pacific (APAC) and the US over the next five years. The CGT market was valued at USD4.99 billion in 2021 and is forecast to reach USD 36.92 billion by 2027.
Biocair UK Cell and Gene Therapy Lead, Kinga Lovasz, commented: “This new team of experts will enhance Biocair’s agility in the field and enable us to develop new logistics solutions, such as advanced packaging and tracking technologies, to ensure materials arrive on-time and in-full anywhere across the globe.”
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
